Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708994 · ClinicalTrials.gov registry record · Early Phase 1
Cannabinoids, Neural Synchrony, and Information Processing
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
NCT00708994 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 42 participants.
The verdict
NCT00708994, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).
Interventions
- DRUG Placebo
- DRUG THC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-02-25 |
| Est. Completion | 2012-12-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00708994
The ClinicalTrials.gov registry entry for NCT00708994 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00708994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00708994 about?
NCT00708994 is a clinical study titled "Cannabinoids, Neural Synchrony, and Information Processing". The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).
What is the current status of trial NCT00708994?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2008-02-25. Estimated completion is 2012-12-03.
What interventions are being tested in trial NCT00708994?
The interventions under investigation include: Placebo (DRUG), THC (DRUG).
Who is sponsoring clinical trial NCT00708994?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.